Home » Stocks » Greenvision Acquisition

Greenvision Acquisition Corp. (GRNV)

Stock Price: $9.99 USD 0.00 (0.00%)
Updated Oct 22, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 71.80M
Revenue (ttm) n/a
Net Income (ttm) -276,042
Shares Out 7.19M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 22, 2020
Last Price $9.99
Previous Close $9.99
Change ($) 0.00
Change (%) 0.00%
Day's Open 10.03
Day's Range 9.98 - 10.03
Day's Volume 6,112
52-Week Range 9.45 - 10.20

More Stats

Market Cap 71.80M
Enterprise Value 71.60M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 7.19M
Float 5.94M
EPS (basic) n/a
EPS (diluted) -0.04
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 34
Short Ratio 0.00
Short % of Float 0.00%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 14.36
Revenue n/a
Operating Income n/a
Net Income -276,042
Free Cash Flow n/a
Net Cash 202,271
Net Cash / Share 0.03
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-0.11
Net Income-0.01
Shares Outstanding1.48
Earnings Per Share-0.03
Operating Cash Flow-0.06
Free Cash Flow-0.06
Cash & Equivalents0.47
Net Cash / Debt0.47
Book Value5.00
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Greenvision Acquisition Corp.
Country United States
CEO Zhi Geng Fu

Stock Information

Ticker Symbol GRNV
Stock Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Unique Identifier NASDAQ: GRNV
IPO Date November 19, 2019


Greenvision Acquisition focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to focus on target businesses operating in the life sciences and healthcare industries in North America, Europe, and Asia. The company was founded in 2019 and is based in New York, New York.